
Aug 31, 2026
Press releaseNew Data at ESC Congress 2026 Validate Caristo's FAI-Score™ Biomarker and Highlight Potential Non-Contrast Cardiac CT Opportunity
—Independent Oxford-led data showcase the value of coronary inflammation assessment in non-contrast cardiac CT, identifying risk even in patients with zero coronary calcium——Late-breaking ORFAN-MAESTRIA data and additional investigator-led analyses highlight broader scientific applications of Caristo's AI platform in future stroke risk prediction—MUNICH, Aug. 31, 2026 /PRNewswire/ -- Caristo Diagnostics, a global leader in AI technologies for cardiovascular disease, today announced new independe








